InsiderTrades

Form 4 for TDOC Teladoc Health, Inc.

Accepted 2023-11-01 00:00:00 ET · period of report 2023-10-30 · accession 0001477449-23-000068 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-11-01 2023-10-31 TDOC Geshuri Arnnon CHRO S - Sale+OE $16.28 -365 77.1K -0.5% -$5,942
D 2023-11-01 2023-10-30 TDOC Geshuri Arnnon CHRO M - OptEx — +1,061 77.5K +1% —
D 2023-11-01 2023-10-30 TDOC Geshuri Arnnon CHRO M - OptEx $0.00 -1,061 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-10-31 S D 365 $16.28 77,097 D — — (F2) Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit award.
2 Common Common Stock 2023-10-30 M A 1,061 — 77,462 D — — (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
3 Derivative Restricted Stock Units 2023-10-30 M D 1,061 $0.00 0 D — · — to — 1,061 Common Stock (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F3) On October 30, 2020, the reporting person was granted 3,181 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.